Dare Bioscience, Inc. has been told it might be removed from Nasdaq for not meeting listing rules.

Oct 2, 2026, 4:06 PM ETTroubleRead the original at SEC EDGAR

Bad for DARE

DARE has until March 29, 2027, to meet Nasdaq's $1.00 closing-bid rule, and its listing remains in place for now. The risk of delisting weighs more because the company says it cannot assure compliance.

DARE · Dare Bioscience, Inc.

AI read · Bad for DARE

The AI's read

The main concern is that DARE could lose its Nasdaq listing if it cannot raise its closing bid enough. It has until March 29, 2027, to meet the rule and may qualify for another 180 days. The listing remains in place for now, but the filing says success is not assured.

Get alerts for DARE

Follow Dare Bioscience, Inc. (DARE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for DARE

Free on the App Store and Google Play, or on the web.